Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$156.60 USD

156.60
1,709,489

-1.64 (-1.04%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $156.62 +0.02 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Ecolab (ECL) Unveils Its Enhanced Smart Water Navigator

by Zacks Equity Research

Ecolab's (ECL) smart tool is expected to bridge the widening gap between freshwater supply and demand via efficient water management.

Zacks Equity Research

AmerisourceBergen (ABC) Hits New 52-Week High: What's Driving It?

by Zacks Equity Research

AmerisourceBergen (ABC) is optimistic about maintaining a robust segmental performance amid the pandemic-led business disruptions.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab

Zacks Equity Research

Cardinal Health (CAH) Hits New 52-week High: What's Driving It?

by Zacks Equity Research

Cardinal Health (CAH) is witnessing an uptrend in its stock price, prompted by robust performance in both Pharmaceutical and Medical segments during the fiscal second quarter.

Trina Mukherjee headshot

MedTech to Gain From Economic Stimulus Bill: 3 Stocks to Buy

by Trina Mukherjee

Grab these three top stocks - ABT, HOLX and BIO - that continue to show tremendous promise and stand to benefit from the historic stimulus package.

Zacks Equity Research

Cardinal Health (CAH) Inks Deal to Divest Cordis Business

by Zacks Equity Research

Cardinal Health (CAH) divests its Cordis business to focus on strategic growth areas.

Zacks Equity Research

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

by Zacks Equity Research

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Zacks Equity Research

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio.

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

by Trina Mukherjee

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Zacks Equity Research

Cardinal Health (CAH) Q2 Earnings & Revenues Top Estimates

by Zacks Equity Research

Cardinal Health's (CAH) fiscal second-quarter results reflect strong segmental performance.

Zacks Equity Research

Cardinal Health (CAH) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Cardinal (CAH) delivered earnings and revenue surprises of 20.00% and 0.01%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in Pharmaceutical segment.

Zacks Equity Research

The Zacks Analyst Blog Highlights: McKesson, Cardinal Health, Becton, Dickinson and Co and Hill-Rom Holdings

by Zacks Equity Research

The Zacks Analyst Blog Highlights: McKesson, Cardinal Health, Becton, Dickinson and Co and Hill-Rom Holdings

Urmimala Biswas headshot

4 Dividend-Paying Undervalued MedTech Stocks for Gains in 2021

by Urmimala Biswas

Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.

Zacks Equity Research

Cardinal Health (CAH) Unveils New Logistics Management Tool

by Zacks Equity Research

Cardinal Health's (CAH) company, OptiFreight Logistics, launched TotalVue Analytics to help healthcare supply chain leaders to drive cost savings.

Zacks Equity Research

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and buyouts.

Zacks Equity Research

Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (CAH) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Simbec-Orion to Adopt Veeva's (VEEV) Vault Applications

by Zacks Equity Research

Veeva's (VEEV) clinical solutions will offer Simbec-Orion real-time insights into studies in phases to accelerate trial execution.

Zacks Equity Research

Acadia Healthcare (ACHC) Forms JV to Boost Service in Detroit Area

by Zacks Equity Research

Acadia Healthcare (ACHC) partners with Henry Ford Health System for offering improved mental health services in Detroit and neighboring counties.

Zacks Equity Research

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

by Zacks Equity Research

Investors grew bullish on Nevro's (NVRO) prospects, courtesy of the stock's solid prospects.

Zacks Equity Research

Veeva (VEEV) Vault Applications Get Adopted by GenesisCare

by Zacks Equity Research

Veeva Systems' (VEEV) clinical capabilities will allow GenesisCare Clinical CRO to rationalize trial procedures and expedite execution of the same.

Zacks Equity Research

Cardinal (CAH) Up 7.4% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Is Cardinal Health (CAH) a Good Value Investor Choice Now?

by Zacks Equity Research

Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Equity Research

Here's Why You Should Invest in Cardinal Health (CAH) Stock

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and buyouts.

Zacks Equity Research

Why You Should Retain Pacific Biosciences (PACB) Stock Now

by Zacks Equity Research

Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of its solid prospects.